In vitro measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET/CT

The standard treatment for head and neck squamous cell carcinoma (HNSCC) is radiotherapy, often in combination with chemotherapy or surgery. However, a novel monoclonal antibody, cetuximab (Erbitux(®)), has also been approved for patient therapy. The aim of present study was to develop an in vitro m...

Descripción completa

Detalles Bibliográficos
Autores principales: Matic, Natasa, Ressner, Marcus, Wiechec, Emilia, Roberg, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788167/
https://www.ncbi.nlm.nih.gov/pubmed/31620196
http://dx.doi.org/10.3892/ol.2019.10916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788167/
https://www.ncbi.nlm.nih.gov/pubmed/31620196
http://dx.doi.org/10.3892/ol.2019.10916

Ejemplares similares